Journal of Stroke10.5853/jos.2019.024742019213241-241Tackling Nonatrial Fibrillation Diseases Using Nonvitamin K Antagonist Oral Anticoagulant: by What and for Whom?Jong S. Kim,,
Journal of Stroke and Cerebrovascular Diseases10.1016/j.jstrokecerebrovasdis.2019.05.01720192892363-2375A Narrative Review of Nonvitamin K Antagonist Oral Anticoagulant Use in Secondary Stroke PreventionValeria Caso, Florian Masuhr,
Clinical Cardiology10.1002/clc.234082020437676-683Real‐world use of nonvitamin K antagonist oral anticoagulant in atrial fibrillation patients with liver disease: A meta‐analysisQixin Dai, Xiaohong Deng, Lin Zhou, Long Zhang, Xiulin Xiao, Yonghui Liao,,,
Therapeutic Advances in Cardiovascular Disease10.1177/17539447177149212017119243-256Nonvitamin K antagonist oral anticoagulant use in patients with renal impairmentAlexander G.G. Turpie, Daniel Purdham, Antonio Ciaccia,,
Archives of Cardiovascular Diseases Supplements10.1016/s1878-6480(17)30541-4201792219Perioperative complications in transcathter aortic valve implantation, in patients with pre existing atrial fibrillation : vitamine K antagonist treatment versus new direct oral anticoagulantC. Caussin,
Journal of the American Association of Nurse Practitioners10.1002/2327-6924.1233020152712721-731Nonvitamin K antagonist oral anticoagulants in everyday practice: Stroke prevention in atrial fibrillation and treatment of venous thromboembolismBarbara A. Bentz,
Trends in Cardiovascular Medicine10.1016/j.tcm.2017.06.0122017278567-572Appropriate dosing of nonvitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillationBenjamin A. Steinberg, Jeffrey B. Washam,
Atrial Fibrillation and Percutaneous Coronary Intervention10.1007/978-3-319-42400-2_4201659-77Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Urgent Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary SyndromeUwe Zeymer
TH Open10.1055/s-0041-173177720210503e353-e362The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial FibrillationJan Beyer-Westendorf, Matthew Fay, Walid Amara
Atrial Fibrillation and Percutaneous Coronary Intervention10.1007/978-3-319-42400-2_2201619-38Atrial Fibrillation on Non-vitamin K Antagonist Oral Anticoagulant Undergoing Elective Percutaneous Coronary Intervention for Stable Effort AnginaPascal Vranckx, Hein Heidbuchel, Marco Valgimigli